Join us   Log in   pharmaspire@isfcp.org  


PHARMASPIRE - Volume 13, Issue 3, July - September, 2021

Pages: 91-113

Date of Publication: 07-Jun-2022


Print Article   Download XML  Download PDF

Structural significance of triazole derivatives for the management of various diseases

Author: Arjun Anant, Priti Singh, Vivek Asati

Category: Pharmaceutics

Abstract:

The 1, 2, 4-triazole ring is an important heterocyclic ring having various synthetic uses. Triazole derivatives have been synthesized and published by various researchers as its important characteristic against various diseases. An emphasis has been given to structure–activity relationship, biological activity, and design strategy of various mono as well as polysubstituted triazoles to ensure the acceptance level of this heterocyclic ring in the field of medicinal chemistry. The derivative of this heterocyclic ring produced various biological activities such as anti-inflammatory, anticonvulsant, hypoglycemic, antitubercular, anxiolytic, antimicrobial, antitumor, and anticancer. The current review article focuses of pharmacological profile associated with 1,2,4-triazoles and mainly focuses on structural modification done for various targets along with brief description of targets.

Keywords: 1, 2, 4-triazoles, 1, 3-triazoles, anti-inflammatory, anticonvulsant, hypoglycemic, antitubercular, anxiolytic, antimicrobial, antitumor, and anticancer

References:

1. Eicher T, Hauptmann S, Speicher A. The chemistry of Heterocycles. 2nd ed. Weinheim: Wiley-VCH GmbH and Co. KGaA; 2003. p. 208.

2. Potts KT. The chemistry of 1, 2, 4-triazoles. Chem Rev 1961;61:108.

3. Kartitzky AR. Hand Book of Heterocyclic Chemistry. 1st ed. New York: Pergamon Press; 1985. p. 87.

4. Eicher T, Hauptmann S, Speicher A. The chemistry of Heterocycles. 2nd ed. Weinheim: Wiley-VCH GmbH and Co. KGaA; 2003. p. 210.

5. Palaska E, Sahin G, Kelincen P, Durlu N, Altionax G. Synthesis and antiinflammatory activity of 1-acyl thiosemicarbazides, 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and 1, 2, 4-triazole-3-thiones. Farmaco 2002;57:101-7.

6. Sharma B, Verma A, Prajapati S, Sharma U. Synthetic methods, chemistry, and the anticonvulsant activity of thiadiazoles. Int J Med Chem 2013;2013:348948.

7. Holla B, Rao B, Sarojini B, Akberali P, Kumari N. Synthesis and studies on some new fluorine containing triazolothiadiazines as possible antibacterial, antifungal and anticancer agents. Eur J Med Chem 2006;41:657-63.

8. Ibrahim D. Synthesis and biological evaluation of 3, 6 disubstituted [1, 2, 4] triazolo [3, 4-b] [1, 3, 4] thiadiazole derivatives as a novel class of potential antitumor agents. Eur J Med Chem 2009;44:2776-81.

9. Zahran F, Abdel-Latif F, Sayed A, Shaban R, Keshta A. Biological studies of the effect of some new synthetic triazole derivatives on Ehrlich Ascites Carcinoma cells. Int J Biol Pharm Res 2013;4:261-70.

10. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 1998;95:13313-8.

11. Warner TD, Giuliano F, Vaynovie I, Bukasa A, Mitchell JA, Vave JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci USA 1999;96:7563-8.

12. Palomer A, Cabre F, Pascual J, Campos J, Trugillo MA, Entrena A, et al. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models. J Med Chem 2002;45:1402-11.

13. Boschelli DH, Connor DT, Bornemeier DA, Dyer RD, Kennedy JA, Kuipers PJ, et al. 1, 3, 4-Oxadiazole, 1, 3, 4-thiadiazole, and 1, 2, 4-triazole analogs of the fenamates: In vitro inhibition of cyclooxygenase and 5-lipoxygenase activities. J. Med Chem 1993;36:1802-10.

14. Lombardino G. Non-Steroidal Anti-Inflammatory Drugs. New York: WileyInter Science, John-Wiley and Sons; 1985. p. 35.

15. Schoen RT, Vender RJ. Mechanism of non-steroidal anti-inflammatory drug-induced gastric damage. Am J Med 1989;86:449-58.

16. Boughton-Smith NK, Whittie BJ. The role of leukotrienes in the pathogenesis of gastric ulceration. Pharm Res Commun 1988;20:919-34.

17. George T, Mehta DV, Tahilramani R, David J, Talwalker PK. Synthesis of some s-triazoles with potential analgesic and anti-inflammatory activities. J Med Chem 1971;14:335-8.

18. Jaiswal RK, Parmar SS, Singh SP, Barthwal JP. Synthesis of 5-(3, 4, 5-trimethoxyphenyl)-4-substituted aryl-3-hydrazino-carbonylmethylthio-4H-1, 2, 4-triazoles was synthesized as possible anti-inflammatory agents. J Heterocycl Chem 1979;16:561.

19. Kothari PJ, Singh SP, Parmar SS, Stenberg VI. Synthesis of some newer 5-(5-aryl-2H-tetrazol-2-ylmethyl)-4-substituted-s-triazole-3-thiols as possible anti-inflammatory agents. J Heterocycl Chem 1980;17:1393.

20. Tandon M, Barthwal JP, Bhalla TN, Bhargava KP. Synthesis and anti-inflammatory activity of some new 3-(o-Substituted phenyl)-4-substituted-phenyl-5-alkyl/ alkenyl-mercapto-1 H-1, 2, 4-triazoles. Indian J Chem 1981;20B:1017.

21. Wade PC, Vogt BR, Kissick TP, Simpkins LM, Palmer DM, Millonig RC. 1-acyltriazoles as anti-inflammatory agents. J Med Chem 1982;25:331-3.

22. Maxwell JR, Wasdahl DA, Wolfson AC, Stenberg VI. Synthesis of 5-aryltetrazoles, 5-aryl-2H-tetrazole-2-acetic acids and [(4-phenyl-5-aryl-4H-1, 2, 4-triazol-3-yl)thio]acetic acids as possible superoxide scavengers and anti-inflammatory agents. J Med Chem 1984;27:1565-70.

23. Prasad AR, Ramalingam T, Rao AB, Diwan PV, Sattur PB. Synthesis and biological evaluation of thiazolo-triazole derivatives. Eur J Med Chem 1989;24:199-201.

24. Pignatello R, Mazzone S, Panico AM, Mazzone G, Pennissi G, Castana R, et al. Synthesis and analgesic activity of some Triazolothiadiazines. Eur J Med Chem 1991;26:929.

25. Sung K, Lee A. Anti-inflammatory activity of some new 3-substituted-4- amino-5-mercapto-4(H)-1, 2, 4-triazoles. J Heterocycl Chem 1992;29:1101.

26. Mullican MD, Wilson MW, Connor DT, Kostlan CR, Schrier DJ, Dyer RD. Design of 5-(3, 5-Di-tert-butyl-4-hydroxyphenyl)-1, 3, 4-thiadiazoles,-1, 3, 4-oxadiazole and-1, 2, 4-triazoles as orally active, nonulcerogenic anti-inflammatory agents. J Med Chem 1993;36:1090-9.

27. Alexander YU, Yuri LK. Synthesis of some triazolyl-antipyrine derivatives and investigation of analgesic activity. Tetrahedron Lett 1995;41:5031.

28. Talwar MB, Bennur SC, Kankanwadi SK, Patil PA. Synthesis and biological evaluation of 3-aryloxyalkyl-6-aryl-7H-s-triazolo [3, 4-b] [1, 3, 4] thiadiazines. Indian J Pharm Sci 1995;57:194.

29. Turan-Zitouni G, Kaplancikli ZA, Erol K, Kilic FS. Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazide, 1, 3, 4-oxadiazole, 1, 3, 4-thiadiazoles and 1, 2, 4-triazoles-3-thiones. Farmaco 1999;54:218-23.

30. Tozkoparan B, Gökhlan N, Aktay G, Ye?ilada E, Ertan M. Synthesis and biological evaluation of substituted 3-alkylthio-4, 5-diaryl-4H-1, 2, 4-triazoles as selective COX-2 inhibitors. Eur J Med Chem 2000;35:743.

31. Turan-Zitouni G, Slvacl M, Kilic FS, Erol K. Synthesis of 5-(2-, 3-and 4-methoxyphenyl)-4-phenyl-4-H-1, 2, 4-triazole-3-thiol derivatives exhibiting anti-inflammatory activity. Eur J Med Chem 2001;36:685.

32. Labanauskas L, Kalcas V, Uderenaite E, Gaidelis P, Brukstus A, Dauksas V. 6-benzylidenethiazolo [3, 2-b]-1,2,4-triazole-5(6H)-ones substituted with ibuprofen: Synthesis, characterization and evaluation of anti-inflammatory activity. Pharmazie 2001;56:617.

33. Palaska E, Sahin G, Kelicen P, Durlu NT, Altinok G. Synthesis and biological evaluation of 3-(2-aroyloxy)methyl-5-mercapto-4H-1, 2, 4-triazole analogues. Farmaco 2002;57:101-7.

34. Labanauskas L Udrenaite E Gaidelis P, Bruk?tus A Synthesis and antiinflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2, 6-dichloroanilino) phenyl]acetic acid derivatives. Farmaco 2004;59:255.

35. Amir M, Shikha K. Synthesis, analgesic, anti-inflammatory and antimicrobial studies of 2, 4-dichloro-5-fluorophenyl containing thiazolotriazoles. Eur J Med Chem 2004;39:535-45.

36. Khanum SA, Shashikanth S, Sudha BS. Condensed bridgehead nitrogen heterocyclic system: Synthesis and pharmacological activities of 1, 2, 4-triazolo-[3, 4-b]-1, 3, 4-thiadiazole derivatives of ibuprofen and biphenyl-4- yloxy acetic acid. Indian J Pharm Sci 2004;66:293.

37. Navidpour L, Shafaroodi H, Abdi K, Amini M, Ghahremani MH, Dehpour AR, et al. 4-alkyl-5-aryl-4H-1, 2, 4-triazole-3-thiols as hypoglycemic agents. Bioorg Med Chem 2006;14:2507.

38. Kumar H, Javed SA, Khan SA, Amir M. 1, 3, 4-oxadiazole/thiadiazole and 1, 2, 4-triazole derivatives of biphenyl-4-yloxy acetic acid: Synthesis and preliminary evaluation of biological properties. Eur J Med Chem 2008;43:2688-98.

39. Upmanyu N, Gupta JK, Shah K, Mishra P. Anti-inflammatory and antinociceptive evaluation of newly synthesized 4-(substituted ethanoyl)amino-3-mercapto-5- (4-methoxy)phenyl-1, 2, 4-triazoles. J Pharm Bioallied Sci 2011;3:259-65.

40. Deniz S, Ayse UB, Banu CT, Elif IS, Inci K, Keriman OS, et al. Novel thiazolo [3, 2-b]-1, 2, 4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: Synthesis, biological evaluation and molecular modelling studies. Bioorg Med Chem 2015;23:2518-28.

41. Mhasalkar MY, Shah MH, Nikam ST, Anantanarayanan KG, Deliwala CV. 4-Alkyl-5-aryl-4H-1, 2, 4-triazole-3-thiols as hypoglycemic agents. J Med Chem 1970;13:672-4.

42. Mhasalkar MY, Shah MH, Nikam ST, Anantanarayanan KG, Deliwala CV. Further studies in substituted 4H-1, 2, 4-triazoles for possible hypoglycemic activity. J Med Chem 1971;14:260-2.

43. Blank B, Nichols DM, Vaidya PD. Synthesis of 1, 2, 4-triazoles as potential hypoglycemic agents. J Med Chem 1972;15:694-6.

44. Agarwal K. Synthesis and pharmacological evaluation of some 3-mercapto-4- substituted Aryl/Alkyl-5-(3-substituted phenylisoxazolo [4, 5-d] pyrimidin-4-yloxymethyl)-1, 2, 4-triazoles as hypoglycemic agents. Indian J Pharm Sci 1991;53:192.

45. Ainsworth C, Nelson R, Easton M. The anticonvulsant activity of 1, 2, 4-triazoles. J Med Chem 1962;5:383-9.

46. Parmar SS, Chaudhary M, Chaudhary AK, Kumar S, Spiro PR. Anticonvulsant activity and selective inhibition of NAD-dependent oxidations in rat brain homogenates by newer mercaptotriazoles. J Pharm Sci 1977;66:971-5.

47. Husain MI, Amir M, Singh E. Synthesis of some new substituted mercaptotriazoles and thiazolidones and their monoamine oxidase inhibitory and anticonvulsant properties. Indian J Chem 1987;26B:251-4.

48. Kane JM, Baron BM, Dudley MW, Sorensen SM, Staeger MA, Miller FP. 2, 4-dihydro-3-H-1, 2, 4-triazol-3-ones as anticonvulsant agents. J Med Chem 1990;33:2772-7.

49. Shrimali M, Dixit KS, Barthwal JP. Synthesis and biological evaluation of substituted indolyl-1, 2, 4-triazoles. J Indian Chem Soc 1991;68:466-9.

50. K???kg?zel ?, K???kg?zel ?G, Rollas S, Ötük-Sani? G, Özdemir O, Bayrak ?, et al. Synthesis of some 3-(Arylalkylthio)-4-alkyl/aryl-5-(4- aminophenyl)- 4H-1, 2, 4-triazole derivatives and their anticonvulsant activity. Farmaco 2004;59:893-901.

51. Mir I, Siddiqui MT. Antituberculosis agents-I α-[5-(2-Furyl)-1, 2, 4-triazol-3- ylthio] acethydrazide and related compounds. Tetrahedron 1970;26:5235-8.

52. Udupi RH, Kulkarni VM, Purushottamachar P, Srinivasalu N. Synthesis and biological screening of bridgehead nitrogen heterocycles: Reactions of 4-(N-pyridylcarboxamido)-5-mercapto-3-substituted-1, 2, 4-triazoles. J India Chem Soc 2002;79:2381.

53. Walczak K, Gondela A, Suwi?ski J. Synthesis and antituberculosis activity of N-aryl-C-nitroazoles. Eur J Med Chem 2004;39:849-53.

54. Shiradkar MR, Murahari KR, Gangadasn HR, Suresh T, Kalyan CA, Panchal D, et al. Clubbed triazoles: A novel approach to antitubercular drugs. Eur J Med Chem 2007;42:807-16.

55. Mali RK, Somani RR, Toraskar MP, Mali KK, Naik PP, Shirodkar PY. Synthesis of some antifungal and anti-tubercular 1, 2, 4-triazole analogues. Int J Chem Tech Res 2009;1:168-73.

56. Gall M, Lathi RA, Rudzik AD, Duchamp DJ, Chidester C, Scahill T. Novel anxiolytic agents derived from alpha-amino-alpha-phenyl-o-tolyl-4H-triazoles and -imidazoles. J Med Chem 1978;21:542-8.

57. Kane JM, Dudley MW, Sorensen SM, Miller FP. 2, 4-dihydro-3H-1, 2, 4-triazole-3-thiones as potential antidepressant agents. J Med Chem 1988;31:1253-8.

58. Varvaresou A, Siatra-Papastaikoudi T, Tsotinis A, Tsantili-Kakoulidou A, Vamvakides A. Synthesis, lipophilicity and biological evaluation of indolecontaining derivatives of 1, 3, 4-thiadiazole and 1, 2, 4-triazole. Farmaco 1998;53:320-6.

59. Suman SP, Bahel SC. Some fungicidal 3-aryl/aryloxymethyl-4- aryl-5- mercapto-1, 2, 4-triazoles and bis-(3-aryloxymethyl-4-aryl-1, 2, 4-triazol-5-yl)-methylene/ethylene disulphides. J Indian Chem Soc 1980;57:420.

60. Heeres J, Backx JJ, Cutsem JV. Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. J Med Chem 1984;27:894-900.

61. Heeres J, Hendrickx R, Vancutsem JJ. Synthesis of some CIS-[2-(2, 4-dichlorophenyl)-2-(1-H-1, 2, 4-triazol-1-methyl)-1, 3-di-oxolan-4-yl] methyl methanesulfonate. J Med Chem 1983;26:611.

62. Eweiss NF, Bahajaj AA, Elsherbini EA. Synthesis and antimicrobial activity of some 4-amino-5-aryl-1, 2, 4-triazole-3-thiones and their derivatives. J. Heterocycl Chem 1986;23:1451-8.

63. Prasad AR, Rao AN, Ramalingam T, Sattur PB. Synthesized and biological activity of 4-amino-3-aryloxyalkyl-5-mercapto-1, 2, 4-triazoles. Indian Drugs 1988;25:301.

64. Muhi-Eldeen Z, Nadir M, Aljobory NR, Husseen F, Stohs SJ. Synthesis and antimicrobial evaluation of 3-(4-tert-amino-2-butynyl) thio and alkyl/ alkenylthio-4, 5-disubstituted-4H-1, 2, 4-triazoles. Eur J Med Chem 1991;26:237-41.

65. Mishra RK, Tewari RK. Synthesis and antifungal activity of some 1, 4-disubstituted-thiosemicarbazides, 2, 5-disubstituted-1, 3, 4-thiadiazoles and 3, 4-disubstituted-5-mercapto-1, 2, 4-triazoles. J Indian Chem Soc 1991;68:110.

66. Holla BS, Kalluraya B, Sridhar KR, Drake E, Thomas LM, Bhandary KK, et al. Synthesis, structural characterization, crystallographic analysis and antibacterial properties of some nitrofuryl triazolo [3, 4-b]-1, 3, 4-thiadiazines. Eur J Med Chem 1994;29:301-8.

67. Gupta R, Sudan S, Kachroo PL, Jain SM. Reaction of 3-substituted-4-amino5-mercapto-1, 2, 4-triazoles with substituted cinnamic acids and showed their antimicrobial and anti-inflammatory activity. Indian J Chem 1996;35B:718.

68. Shivarama-Holla B, Gonsalves R, Shenoy S. Studies on some N-bridged heterocycles derived from BIS-[4-amino-5-mercapto-1, 2, 4-triazol-3-yl] alkanes. Farmaco 1998;8-9:574-8.

69. Tsukuda T, Shiratori Y, Watanabe M, Ontsuka H, Hattori K. Modelling synthesis and biological activity of novel antifungal agents (1). Bioorg Med Chem 1998;8:1819-24.

70. Sui Z, Guan J, Hlasta DJ, Macielay MJ, Foleno BD, Goldschmidt RM, et al. SAR studies of diaryltriazoles against bacterial two-component regulatory systems and their antibacterial activities. Bioorg Med Chem 1998;8:1929-34.

71. Udupi RH, Kushnoor A, Bhat AR. Synthesis and biological evaluation of some substituted 1, 2, 4-triazoles. J Indian Chem Soc 1999;76:461-2.

72. Demirayak ?, Benkli K, Güven K. Synthesis and antimicrobial activities of some 3-arylamino-5-[2-(substituted 1-imidazolyl)ethyl]-1, 2, 4-triazole derivatives. Eur J Med Chem 2000;35:1037-40.

73. Sangapure SS, Basawaraj R. Synthesis and antimicrobial activities of some1, 3, 4-oxaziazoles, thiadiazoles, triazoles and related compounds possessing benzofuran moiety. Indian J Pharm Sci 2004;66:221.

74. Rao GK, Rajasekaran S, Attimarad M. Synthesis and antimicrobial activity of some 5-phenyl-4-substituted amino-3-mercapto-(4H)-1, 2, 4-triazoles. Indian J Pharm Sci 2000;62:475-7.

75. Ulusoy N, Gürsoy A, Ötük G. Synthesis and antimicrobial activity of some 1, 2, 4-triazole-3-mercaptoacetic acid derivatives. Farmaco 2001;56:947-52.

76. Shivarama-Holla B, Sarojini BK, Rao BS, Akberali PM, Kumari NS, Shetty V. Synthesis of some halogen-containing 1, 2, 4-triazolo-1, 3, 4-thiadiazines and reported their antibacterial and anticancer screening studies. Farmaco 2001;56:965.

77. Küçükgüzel I, Küçükgüzel SG, Rollas S, Kiraz M. Some 3-thioxo/alkylthio-1, 2, 4-triazoles with a substituted thiourea moiety as possible antimycobacterials. Bioorg Med Chem 2001;11:1703-7.

78. Papakonstantinou-Garoufalias S, pouli N, Marakos P, Chytyroglou-Ladas A. Synthesis antimicrobial and antifungal activity of some new 3-substituted derivatives of 4-(2, 4-dichlorophenyl)-5-adamantyl-1-H-1, 2, 4-triazole. Farmaco 2002;57:973-7.

79. Patel KD, Mistry BD, Desai KR. Synthesis and antimicrobial activity of 1, 2, 4-triazoles. J Indian Chem Soc 2002;79:964-5.

80. Ravi TK, Rajkannan R. Synthesis and antimicrobial activity of some new 1, 2, 4-triazoles. Indian J Pharm Sci 2004;12:349.

81. Klime?ovà ?, Zahajskà L, Waisser K, Kaustovà J, Möllmann U. Synthesis and antimycobacterial activity of 1, 2, 4-triazole 3-benzylsulfanyl derivatives. Farmaco 2004;59:279-88.

82. Demirbas N, Karaoglu SA, Demirbas A, Sancak K. Synthesis and reported antimicrobial activities of some new 1-(5-phenylamino-[1, 3, 4] thiadiazol-2-yl) methyl-5-oxo-[1, 2, 4]-triazole and 1-(4-phenyl-5-thioxo-[1, 2, 4]-triazol-3-yl) methyl-5-oxo-[1, 2, 4] triazole derivatives. Eur J Med Chem 2004;39:793-804.

83. Holla BS, Mahalinga M, Karthikeyan MS, Poojary B, Akberali PM, Kumari NS. Synthesis, characterization and antimicrobial activity of some substituted 1, 2, 3-triazoles. Eur J Med Chem 2005;40:1173-8.

84. Turan-Zitouni G, Kaplancikli ZA, Yildiz MT, Chevallet P, Kaya D. Synthesis of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]thio-4H-1,2,4-triazole. Eur J Med Chem 2005;40:607-13.

85. Ozkirimli S, Apak TI, Kiraz M, Yegenoglu Y. Synthesis of new triazolyl-N, N-dialkyldithiocarbamate as antifungal agents. Arch Pharm Res 2005;28:1213-8.

86. Siddiqui AA, Arora A, Siddiqui N, Misra A. Synthesis of some1, 2, 4-triazoles as potential antifungal agents. Indian J Chem 2005;44B:838.

87. Mathew V, Keshavayya J, Vaidya VP. Heterocyclic system containing bridgehead nitrogen atom: Synthesis and pharmacological activities of some substituted 1, 2, 4-triazolo [3, 4-b]-1, 3, 4-thiadiazoles. Eur J Med Chem 2006;41:1048-58.

88. Sztanke K, Pasternak K, Sidor-w?jtowicz A, Truchli?ka J, J??wiaka K. Synthesis of imidazo [2, 1-c] [1, 2, 4] triazole aryl derivative containing the methylthio group as possible antibacterial agents. Bioorg Med Chem 2006;14:3635-42.

89. Swamy SN, Priya BS, Prabhuswamy B, Doreswamy BH, Prasad JS, et al. Synthesis of pharmaceutically important condensed heterocyclic 4, 6-disubstituted-1, 2, 4-triazolo-1, 3, 4-thiadiazole derivatives as antimicrobials. Eur J Med Chem 2006;41:531-8.

90. Holla BS, Rao BS, Sarojini BK, Akberali PM, Kumari NS. Synthesis and studies on some new fluorine containing triazolothiadiazines as possible antibacterial, antifungal and anticancer agents. Eur J Med Chem 2006;41:657-63.

91. El-Sayed R. Synthesis, antibacterial and surface activity of 1, 2, 4-triazole derivatives. Indian J Chem 2006;45B:738.

92. Baluja S, Chanda S, Chabhadiya R, Kachhadiya N, Nair R, Solanki A. A facile synthesis and the antimicrobial activity of some 4-aryltriazoles. J Serb Chem Soc 2007;72:539-44.

93. Khiati Z, Othman AA, Guessas B. Synthesis and antibacterial activity of 1, 3, 4-oxadiazole and 1, 2, 4-triazole derivatives of salicylic acid and its synthetic intermediates. S Afr J Chem 2007;60:20-4.

94. Serdar M, Gümrürfüo?lu N, Karao?lu ?A, Demirbaz N. Synthesis of some novel 3, 5-diaryl-1, 2, 4-triazole derivatives and investigation of their antimicrobial activities Turk J Chem 2007;31:315-26.

95. Ezabadi IR, Camoutsis C, Zoumpoulakis P, Geronikaki A, Sokovic M, Glamo?ilija J, et al. Sulfonamide-1, 2, 4-triazole derivatives as antifungal and antibacterial agents: Synthesis, biological evaluation, lipophilicity, and conformational studies. Bioorg Med Chem 2008;16:1150-61.

96. Havaldar FH, Patil AR. Syntheses of 1, 2, 4 triazole derivatives and their biological activity. E J Chem 2008;5:347-54.

97. Kplancikli ZA, Turan-zitouni G, Özdemir A, Revial G. New triazole and triazolothiadiazine derivatives as possible antimicrobial agents. Eur J Med Chem 2008;43:155-9.

98. Chen Q, Zhu XL, Liu Z, Yang G. Synthesis, antifungal activity and CoMFA analysis of novel 1, 2, 4-triazolo [1, 5-a] pyrimidine derivatives. Eur J Med Chem 2008;43:595-603.

99. Rezaei Z, Khabnadideh S, Pakshir K, Hossaini Z, Amiri F, Assadpour E. Design, synthesis, and antifungal activity of triazole and benzotriazole derivatives. Eur J Med Chem 2009;44:3064-7.

100. Karthikeyan MS, Holla BS, Kumari NS. Synthesis and antimicrobial studies of novel dichlorofluorophenyl containing aminotriazolothiadiazines. Eur J Med Chem 2008;43:309-14.

101. Upmanyu N, Kumar S, Kharya MD, Shah K, Mishra P. Synthesis and antimicrobial evaluation of some novel 1, 2, 4-triazole derivatives. Acta Pol Pharm 2011;68:213-21.

102. Kumar R, Yar MS, Srivastava B, Rai AK. Synthesis, characterization and biological evaluation of novel 1, 2, 4-triazole derivatives as potent antibacterial and anti-inflammatory agents. Pharm Chem 2014;6:137-43.

103. Kini GD, Robins RK, Avery TL. Synthesis and antitumor activity of ribavirin imidates. New facile synthesis of ribavirin amidine (1β-D-ribofuranosyl-1, 2, 4-triazole-3-carboxamidine hydrochloride). J Med Chem 1989;32:1447-9.

104. Ikizler AA, Uzunali E, Demirbas A. Synthesis of some 1, 2, 4-triazole derivatives as potential antitumor agents. Indian J Pharm Sci 2000;62:371.

105. Holla BS, Poojary KN, Rao S, Shivananda MK. New bis-aminomercaptotriazoles and bis-triazolothiadiazoles as possible anticancer agents. Eur J Med Chem 2002;37:511-7.

106. Demirbas N, Ugurluoglu R, Demirba? A. Synthesis of 3-alkyl(aryl)-4- alkylideneamino-4, 5-dihydro-1H-1, 2, 4-triazole-5-ones and 3-alkyl 4-alkylamino-4, 5-dihydro-1H-1, 2, 4-triazole-5-ones as antitumor agents. Bioorg Med Chem 2002;10:3717-23.

107. Al-Soud YA, Al-Masoud NA, Ferwanah AE. Synthesis and properties of new substituted 1, 2, 4-triazoles: Potential antitumor agents. Bioorg Med Chem 2003;11:1701-8.

108. Holla BS, Veerendra B, Shivananda MK, Poojary B. Synthesis, characterization and anticancer activity studies on some mannich bases derived from 1, 2, 4-triazole. Eur J Med Chem 2003;38:759-67.

109. Pomarnacka E, Gdaniec M. Synthesis and anticancer activity of 2-amino-8- chloro-5, 5-dioxo [1, 2, 4] triazole [2, 3-b] [1, 4, 2] benzodithiazine derivatives. Bioorg Med Chem 2003;11:1259-67.

110. Al-Soud Y, Masoudi NA. DNA-directed alkylating agents: Synthesis, antitumor activity and DNA affinity of bis-N, N’-trisubstituted 1, 2, 4-triazolopiperazines. Farmaco 2004;59:41-6.

111. Al-Soud Y, Al-Dweri MN, Al-Masoudi NA. Synthesis, antitumor and antiviral properties of some 1, 2, 4-triazoles derivatives. Farmaco 2004;59:775-83.

112. Bekircan O, Gümrükçüo?lu N. Synthesis of some 3, 5-diphenyl-4H-1, 2, 4-triazole derivatives as antitumor agents. Indian J Chem 2005;44B:2107-13.

113. Victoriya G, Lina P, Narzullo S, Idibeg K. Docking studies and biological evaluation of anticancer activity of new 1, 2, 4-triazole (4H) derivatives. Scr Sci Pharm 2014;2:46-53.

114. Georgiyants V, Perekhoda L, Saidov N, Kadamov I. Docking studies and biological evaluation of anti-cancer activity of new 1, 2, 4-triazole (4H) derivatives. Scr Sci Pharm 2014;2:46-53.

115. Benci K, Suhina T, Mandic L, Pavelic SK, Paravic AT, Pavelic K, et al. Novel 1, 2, 4-triazole and purine acyclic cyclopropane nucleoside analogue: Synthesis, antiviral and cytostatic activity evaluations. Antivir Chem Chemother 2011;21:221-30.

116. Omar AM, Aboulwafa OM. Novel Estradiol-17α-1, 2, 4-triazole derivatives: Synthesis and in vitro anabolic-catabolic properties and binding affinity to steroid receptors. J Heterocycl Chem 1984;21:1419-23.

117. Witkowski JT, Robins RK, Sidwell RW, Simon LN. Design, synthesis, and broad spectrum antiviral activity of 1-beta-D dribofuranosyl-1, 2, 4-triazole-3- carboxamide and related nucleosides. J Med Chem 1972;15:1150-4.

118. Bradbury RH, Rivett JE. 1, 2, 4-Triazolo [4, 3-a] pyrazine derivatives with human renin inhibitory activity. 3. Synthesis and biological properties of aminodeoxystatine and difluorostatone derivatives. J Med Chem 1991;34:151-7.

119. Ashton WT, Cantone CL, Chang LL, Hutchins SM, Strelitz RA, MacCossM, et al. Nonpeptide angiotensin II antagonists derived from 4H-1, 2, 4-triazoles and 3H-imidazo [1, 2-b] [1, 2, 4] triazoles. J Med Chem 1993;36:591-609.

120. Kane JM, Staeger MA, Dalton CR, Miller FP, Dudley MW, Ogden AL, et al. 5-Aryl-3-(alkylthio)-4H-1, 2, 4-triazoles as selective antagonists of strychnine-induced convulsions and potential anti-spastic agents. J Med. Chem 1994;37:125-32.

121. Naito Y, Akahosi F, Takeda S, Okada T, Kajii M, Nishimura H, et al. Synthesis and pharmacological activity of triazole derivatives inhibiting eosinophilia. J Med Chem 1996;39:3019-29.

122. Mark SC, Leslie JS, Simon G, Sarah CH, Peter H, Richard AJ. 3-(Piperazinylpropyl) indoles: Selective, orally bioavailable h5-ht1d receptor agonists as potential anti-migraine agents. J Med Chem 1999;42:691-705.

123. Demirayak S, Karaburun AC, Mohson U, Guven K. Synthesis and antithyroid activity of 3-amino-1, 2, 4-triazole. Acta Pharm Turc 1999;41:78.

124. Romine JL, Martin SW, Gribkoff VK, Boissard CG, Dworetzky SI, Natale J, et al. 4, 5-Diphenyltriazol-3-ones: Openers of large-conductance Ca2 activated potassium (maxi-K) channels. J Med Chem 2002;45:2942-52.

125. Bing C, Xuhong Q, Song C, Haidong L, Gonghun S. Synthesis and insecticidal activity of 2-t-Butyl-4-chloro 5[(3-(substituted)-1H-1, 2, 4-triazol-5yl)thio] pyridazin-3H-2one derivatives. Arkivoc 2003;2:141.

126. Haydar Y, Murat K, Muzaffer A, Sule B, Sevgi K, Zafer O. Antiradical and antioxidant activity of 1, 2, 4-triazole derivatives. Asian J Chem 2006;18:539-50.

127. Kim D, Kim J, Park HJ. Design, synthesis, and biological evaluation of novel 2-pyridinyl-[1, 2, 4] triazoles as inhibitors of transforming growth factor β1 Type 1 receptor. Bioorg Med Chem 2004;12:2013-20.

128. Jin J, Chen X, Zhang A, Zhang H. Syntheses and biological activities of 6-aryl-3- (3-hydroxy-propyl)-7h-1, 2, 4-triazolo [3, 4-b] [1, 3, 4] thiadiazines. Molecules 2007;12:297-330.

129. Sarva MC, Romeo G, Guerrera F, Siracusa M, Salernol L, Russo F, et al. [1, 2, 4] Triazole derivatives as 5-HT1A serotonin receptor ligands. Bioorg Med Chem 2002;10:313-23.

130. Baldwin JJ, Kasinger PA, Novello PC, Sprague JM, Duggan DE. 4-Trifluoromethylimidazoles and 5-(4-pyridyl)-1,2,4-triazoles, new classes of xanthine oxidase inhibitors. J Med Chem 1975;18:895-900.

131. Akerblom EB, Campbell DE. Nitrofuryltriazole derivatives as potential urinary tract antibacterial agents. J Med Chem 1973;16:312-9.

132. Yadagiri B, Gurrala S, Bantu R, Nagarapu L, Polepalli S, Srujana G, et al. Synthesis and evaluation of benzosuberone embedded with 1, 3, 4-oxadiazole, 1, 3, 4-thiadiazole and 1, 2, 4-triazole moieties as new potential anti proliferative agents. Bioorg Med Chem Lett 2015;25:2220-4.

133. Georgiyants V, Perekhoda L, Saidov N, Kadamov I. Synthesis, docking studies and biological evaluation of anti-ulcer activity of 4-allyl-5-(4-R1)- phenylthiomethyl-1, 2, 4-triazole-3-ylmercaptoacetic acid derivatives. Eur Chem Bull 2014;3:466-71.